MAP4K1 and non-small cell lung carcinoma: Bai et al. had shown that PDIA6 is overexpressed in non-small cell lung cancer cells (NSCLC) and its overexpression can inhibit cisplatin-induced cell apoptosis and autophagy via the MAP4K1/JNK/c-Jun signaling pathway [33].